HEIP
ABBV icon

Hudson Edge Investment Partners’s AbbVie ABBV Stock Holding History

Hudson Edge Investment Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.62M Sell
30,279
-2,464
-8% -$530K 1.04% 24
2026
Q1 		$7.12M Buy
32,743
+2,212
+7% +$491K 1.04% 41
2025
Q4 		$6.98M Sell
30,531
-1,276
-4% -$291K 1.03% 40
2025
Q3 		$7.36M Sell
31,807
-2,700
-8% -$550K 1.19% 27
2025
Q2 		$6.41M Buy
34,507
+4,235
+14% +$787K 1.1% 31
2025
Q1 		$6.34M Sell
30,272
-9,052
-23% -$1.76M 1.29% 23
2024
Q4 		$6.99M Buy
39,324
+5,713
+17% +$1.05M 1.29% 13
2024
Q3 		$6.64M Sell
33,611
-4,639
-12% -$866K 1.23% 19
2024
Q2 		$6.56M Buy
38,250
+751
+2% +$124K 1.27% 10
2024
Q1 		$6.83M Sell
37,499
-4,123
-10% -$711K 1.33% 10
2023
Q4 		$6.45M Sell
41,622
-878
-2% -$128K 1.5% 10
2023
Q3 		$6.33M Sell
42,500
-2,452
-5% -$360K 2.07% 5
2023
Q2 		$6.06M Buy
44,952
+3,795
+9% +$557K 1.93% 10
2023
Q1 		$6.56M Buy
41,157
+2,465
+6% +$377K 2.04% 3
2022
Q4 		$6.25M Sell
38,692
-993
-3% -$152K 2.13% 4
2022
Q3 		$5.33M Sell
39,685
-1,721
-4% -$247K 1.98% 4
2022
Q2 		$6.34M Sell
41,406
-968
-2% -$148K 2.31% 2
2022
Q1 		$6.87M Sell
42,374
-10,415
-20% -$1.51M 2.16% 2
2021
Q4 		$7.15M Sell
52,789
-2,781
-5% -$329K 2.21% 3
2021
Q3 		$5.99M Buy
55,570
+11,943
+27% +$1.36M 1.97% 4
2021
Q2 		$4.91M Sell
43,627
-890
-2% -$100K 1.56% 23
2021
Q1 		$4.82M Sell
44,517
-1,763
-4% -$189K 1.59% 24
2020
Q4 		$4.96M Buy
46,280
+811
+2% +$77.9K 1.77% 11
2020
Q3 		$3.98M Sell
45,469
-21,613
-32% -$2.03M 1.6% 18
2020
Q2 		$6.59M Sell
67,082
-14,320
-18% -$1.26M 2.12% 5
2020
Q1 		$6.2M Sell
81,402
-3,986
-5% -$340K 2.36% 3
2019
Q4 		$7.56M Sell
85,388
-8,302
-9% -$689K 1.99% 7
2019
Q3 		$7.09M Buy
93,690
+28,760
+44% +$1.97M 1.99% 10
2019
Q2 		$4.72M Buy
64,930
+58,618
+929% +$4.61M 1.37% 47
2019
Q1 		$509K Sell
6,312
-1,380
-18% -$113K 0.15% 68
2018
Q4 		$709K Sell
7,692
-200
-3% -$17.6K 0.22% 60
2018
Q3 		$746K Buy
7,892
+996
+14% +$94.5K 0.13% 66
2018
Q2 		$639K Buy
6,896
+46
+0.7% +$4.49K 0.12% 84
2018
Q1 		$648K Sell
6,850
-985
-13% -$108K 0.1% 66
2017
Q4 		$758K Sell
7,835
-415
-5% -$39.1K 0.1% 63
2017
Q3 		$733K Sell
8,250
-80
-1% -$6.09K 0.1% 64
2017
Q2 		$604K Hold
8,330
– – 0.08% 82
2017
Q1 		$543K Sell
8,330
-100
-1% -$6.29K 0.07% 96
2016
Q4 		$528K Buy
8,430
+50
+0.6% +$3.05K 0.07% 98
2016
Q3 		$529K Buy
8,380
+2,340
+39% +$151K 0.08% 85
2016
Q2 		$374K Sell
6,040
-30
-0.5% -$1.83K 0.06% 116
2016
Q1 		$347K Sell
6,070
-1,865
-24% -$104K 0.03% 164
2015
Q4 		$470K Buy
7,935
+975
+14% +$56.2K 0.05% 115
2015
Q3 		$379K Buy
6,960
+300
+5% +$19.5K 0.02% 120
2015
Q2 		$447K Buy
6,660
+40
+0.6% +$2.61K 0.02% 121
2015
Q1 		$388K Buy
6,620
+3,120
+89% +$188K 0.02% 130
2014
Q4 		$229K Hold
3,500
– – 0.01% 140
2014
Q3 		$202K Buy
+3,500
New +$194K 0.01% 145

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Hudson Edge Investment Partners's ABBV Position: Q2 2026 in Review

Hudson Edge Investment Partners reduced its AbbVie (ABBV) stake by 7.5% in Q2 2026, selling an estimated $530K and leaving 30,279 shares worth $7.62M. The position accounts for 1.04% of the portfolio, ranked #24.

Hudson Edge Investment Partners first reported a position in ABBV in Q3 2014 and has held it in 48 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Hudson Edge Investment Partners held 30,279 shares of AbbVie worth $7.62M as of Q2 2026.
  • Hudson Edge Investment Partners sold 2,464 AbbVie shares in Q2 2026, an estimated $530K.
  • AbbVie made up 1.04% of Hudson Edge Investment Partners's portfolio in Q2 2026, its #24 holding.
  • Hudson Edge Investment Partners first reported a position in AbbVie in Q3 2014 and has held it in 48 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hudson Edge Investment Partners's 13F filing for Q2 2026, filed 29 Jul 2026.